{
    "2014-10-14": [
        "When you gotta beat consensus, two Johnsons are better than one.",
        "We're continuing to make very good progress on our near-term priorities & advancing long-term growth drivers.\", \"Johnson & Johnson Q3 EPS USD 1.50 vs. Exp. USD 1.44",
        "Zimmer, Stryker have postive read-through from J&J, says Wells Fargo",
        "Rises On EPS and Revenue for Quarter Ended September 2014"
    ]
}